Throughout Bladder Cancer Awareness Month, patients, professionals and the public have come together to raise awareness and funds for a vital cause. Practitioners the world over know all too well just how little bladder cancer is publicised and discussed within the media, which then contributes to a lack of knowledge and understanding among the general public. As you may be aware, Bladder Cancer is currently the 4th most common cancer in the UK, claiming over 5,000 lives in this country alone and the 5th most common in the western world.
However, not enough is being done to initiate conversations and educate about this relentless disease. The same attention that is given to other cancers, such as breast cancer, is needed in order to accelerate developments in the diagnosis and treatment of bladder cancer in order to catch it at the crucial early stages. This will allow treatment to commence quickly and efficiently, boosting long-term survival rates and saving thousands of lives.
Fight Bladder Cancer
Fight Bladder Cancer, a the only UK-based bladder cancer charity founded and run by bladder cancer survivors and their families, have launched their biggest ever bladder cancer awareness month campaign this May. The driving force behind this initiative is the fact that a late diagnosis is all too often the main cause of a poor outcome. Current treatments often fail to tackle this aggressive disease, especially with a lack of treatment innovation within the last 4 decades.
Alarmingly, under 1 percent of overall cancer research funding is currently directed towards bladder cancer, consequently stunting treatment and diagnosis progression, unlike the strides being made with other common cancers, including lung, bowel and pancreatic cancers. It is as important as ever that we work to bring bladder cancer to the forefront of innovation and eliminate its reputation as a “forgotten cancer.”
Shedding Light On Unanswered Questions
There is a lot to be learned from this international Fight Bladder Cancer campaign. This May a new scientific study showed how tumours have the ability to undertake a period of dormancy in order to cleverly survive, undetected, within the patient. This new information has shed some light on the unanswered question as to why cancer sometimes returns, even after successful diagnosis and treatment.
The dormancy period is a crucial time for tumour progression, allowing the cancerous cells to overcome survival challenges, which is why more needs to be done to further our capabilities of detecting dormant cells and eliminating them. This is easier said than done as dormant cancer cells are often so small that they produce no symptoms, and even if they were successfully detected, these metabolically inactive cells are unlikely to be affected by conventional therapies and treatments.
It is clear that there is still a way to go in the fight against bladder cancer, which is why the passionate Arquer Diagnostics team are dedicated to innovating modern cancer diagnosis and monitoring through the development and commercialisation of MCM5 protein-based and non-invasive tests. We have already launched ADXBLADDER, a highly accurate and highly reliable urine test for bladder cancer, meeting the demand for an alternative to traditional methods that are both costly and uncomfortable for the patient. Visit our website and get in touch to find out how you can offer this groundbreaking lifeline to your patients.